← Back to Patent Explorer
US5158761A Expired / Lapsed US ⏱️ 0.0 years remaining

Spray gel base and spray gel preparation using thereof

Assignee: Toko Yakuhin Kogyo KK
•
Filing: 1990-03-20
•
Granted: 1992-10-27
•
Expires: 2010-03-20
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A spray base gel having an excellent spread-stick property, which is prepared by thickening a 0.2-1.5% by weight aqueous solution of carboxyvinyl polymer with a water-soluble basic substance, followed by adjusting the viscosity thereof with a viscosity adjustor within the range of 500-5,000 centipoise so that the particle size distribution of spray after spraying is over 80% in the area of 20-100 μm and a spray gel preparation having an excellent spread-stick property, which is prepared by mixing an active medicament with said spray gel base.

Inventors

  • 👤 Takuzo Kamishita
  • 👤 Takashi Miyazaki
  • 👤 Yoshihide Okuno

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-08 12:16
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/0012; A61K9/0014; A61K47/00; A61K47/30; A61K47/32; A61K9/0043

Claims Analysis

Total Claims: 15
Claim 1
Independent Claim 130 words
A gel preparation for spray into a nasal cavity comprising an aqueous gel of a carboxyvinyl polymer having a viscosity of 500-5,000 centipoise and pH 4-9, which is prepared by thickening a 0.2-1.5% by weight aqueous solution of carboxyvinyl polymer with a water-soluble basic substance selected from the group consisting of sodium hydroxide, potassium hydroxide, ammonia, alkylamines, dialkylamines, trialkylamines, alkanolamines, dialkanolamines, trialkanolamines, and amino acids in an amount which is necessary for neutralization to adjust the pH value of the aqueous solution of carboxyvinyl polymer to pH 4-9, followed by adjusting the viscosity within the range of 500-5,000 centipoise, and an effective amount of an influenza vaccine selected from the group consisting of virus particle vaccine, HA vaccine, live virus vaccine, artificial membrane vaccine, genetic manipulated vaccine and peptide vaccine.
Claim 2
Dependent Claim 130 words
A gel preparation for spray into a nasal cavity comprising an aqueous gel of a carboxyvinyl polymer having a viscosity of 500-5,000 centipoise and pH 4-9, which is prepared by thickening a 0.2-1.5% by weight aqueous solution of carboxyvinyl polymer with a water-soluble basic substance selected from the group consisting of sodium hydroxide, potassium hydroxide, ammonia, alkylamines, dialkylamines, trialkylamines, alkanolamines, dialkanolamines, trialkanolamines, and amino acids in an amount which is necessary for neutralization to adjust the pH value of the aqueous solution of carboxyvinyl polymer to pH 4-9, followed by adjusting the viscosity within the range of 500-5,000 centipoise, and an effective amount of an influenza vaccine selected from the group consisting of virus particle vaccine, HA vaccine, live virus vaccine, artificial membrane vaccine, genetic manipulated vaccine and peptide vaccine.
Claim 3
Independent Claim 205 words
A method of delivering a medicament by spraying into the nasal cavity which comprises: adding an effective amount of an influenza vaccine selected from the group consisting of virus particle vaccine, HA vaccine, live virus vaccine, artificial membrane vaccine, genetic manipulated vaccine and peptide vaccine to a gel base for spray to form a gel preparation, wherein said gel base comprises an aqueous gel of a carboxyvinyl polymer having a viscosity of 500-5,000 centipoise and pH 4-9, which is prepared by thickening a 0.2-1.5% by weight aqueous solution of carboxyvinyl polymer with a water-soluble basic substance selected from the group consisting of sodium hydroxide, potassium hydroxide, ammonia, alkylamines, dialkylamines, trialkylamines, alkanolamines, dialkanolamines, trialkanolamines, and amino acids in an amount which is necessary for neutralization to adjust the pH value of the aqueous solution of carboxyvinyl polymer to pH 4-9, followed by adjusting the viscosity thereof with a viscosity adjustor selected from the group consisting of sodium chloride, potassium chloride and calcium chlorine in an amount which is necessary for adjusting the viscosity within the range of 500-5,000 centipoise, and administering said gel preparation to a subject in need an effective amount of an influenza vaccine selected from the thereof by spraying into a nasal cavity.
Claim 4
Independent Claim 205 words
A method of delivering a medicament by spraying into the nasal cavity which comprises: adding an effective amount of an influenza vaccine selected from the group consisting of virus particle vaccine, HA vaccine, live virus vaccine, artificial membrane vaccine, genetic manipulated vaccine and peptide vaccine to a gel base for spray to form a gel preparation, wherein said gel base comprises an aqueous gel of a carboxyvinyl polymer having a viscosity of 500-5,000 centipoise and pH 4-9, which is prepared by thickening a 0.2-1.5% by weight aqueous solution of carboxyvinyl polymer with a water-soluble basic substance selected from the group consisting of sodium hydroxide, potassium hydroxide, ammonia, alkylamines, dialkylamines, trialkylamines, alkanolamines, dialkanolamines, trialkanolamines, and amino acids in an amount which is necessary for neutralization to adjust the pH value of the aqueous solution of carboxyvinyl polymer to pH 4-9, followed by adjusting the viscosity thereof with a viscosity adjustor selected from the group consisting of sodium chloride, potassium chloride and calcium chlorine in an amount which is necessary for adjusting the viscosity within the range of 500-5,000 centipoise, and administering said gel preparation to a subject in need an effective amount of an influenza vaccine selected from the thereof by spraying into a nasal cavity.
Claim 5
Dependent Claim 19 words
The method according to claim 2, wherein said influenza vaccine is dissolved by adding a solubilizer or with solvent.
Claim 6
Dependent Claim 17 words
The method according to claim 2, wherein said influenza vaccine is suspended by adding a suspending agent.
Claim 7
Dependent Claim 15 words
The method according to claim 2, wherein the gel preparation has a pH of 6.0-8.0.
Claim 8
Dependent Claim 16 words
The gel preparation according to claim 1, which is for application to mucous membrane or skin.
Claim 9
Dependent Claim 21 words
The gel preparation according to claim 1, wherein the influenza vaccine is dissolved by adding a solubilizer or with a solvent.
Claim 10
Dependent Claim 18 words
The gel preparation according to claim 1, wherein the influenza vaccine is suspended by adding a suspending agent.
Claim 11
Dependent Claim 17 words
The gel preparation according to claim 1, which has a pH value within the range of 6.0-8.0.
Claim 12
Dependent Claim 21 words
The gel preparation according to claim 6, wherein the influenza vaccine is dissolved by adding a solubilizer or with a solvent.
Claim 13
Dependent Claim 18 words
The gel preparation according to claim 6, wherein the influenza vaccine is suspended by adding a suspending agent.
Claim 14
Dependent Claim 17 words
The method according to claim 2, wherein said gel preparation is applied to mucous membrane or skin.
Claim 15
Dependent Claim 16 words
The method according to claim 2, wherein the gel preparation is sprayed into a nasal cavity.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1995-10-27 1996-04-27 1996-10-27 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1999-10-27 2000-04-27 2000-10-27 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2003-10-27 2004-04-27 2004-10-27 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag